Autoimmune Diseases  >>  SB-509  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SB-509 / Biogen
NCT00406458: Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Completed
2
110
US, RoW
SB-509, Normal Saline
Sangamo Therapeutics, Juvenile Diabetes Research Foundation
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Polyneuropathy
12/08
05/09
NCT00665145: Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509

Completed
2
23
US
SB-509, Placebo
Sangamo Therapeutics
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Polyneuropathy
10/09
10/09
NCT00476931: Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Completed
2
91
US, RoW
SB-509, Placebo
Sangamo Therapeutics
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Polyneuropathy
07/10
12/10

Download Options